Evidence map›Paper›PMID 26639180›Full record

ArticleLeukemia2016

Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia.

C Song, X Pan, Z Ge, C Gowda, Y Ding, H Li, Z Li, G Yochum, M Muschen, Q Li and 2 more

Open access · hybridAbstract readLetter
In one paragraph

Article in Leukemia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Biomedicines · 2024
    Review
  9. Review
  10. IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

C SongDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
X PanDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
Z GeDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
C GowdaDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
Y DingDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
H LiDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
Z LiDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
G YochumDepartment of Biochemistry and Molecular Biology, Pennsylvania State University Medical College, Hershey, PA, USA.
M MuschenUniversity of California San Francisco, San Francisco, CA, USA.
Q LiDepartment of Statistics, Pennsylvania State University, University Park, State College, PA, USA.
K J PayneDepartment of Pathology and Human Anatomy and Center for Health Disparities and Molecular Medicine, Loma Linda University, Loma Linda, CA, USA.
S DovatDepartment of Pediatrics, Pennsylvania State University Medical College, Hershey, PA, USA.
Penn State Milton S. Hershey Medical Center · USPennsylvania State University · USLoma Linda University · USUniversity of California, San Francisco · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
Penn State Clinical and Translational Science InstituteUL1TR000127 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2012 to 2015
$17.1M
Metabolic gatekeepers in B-cell malignanciesR35CA197628 · NCI · YALE UNIVERSITY · PI Markus Müschen · 2016 to 2026
$11.7M
NIH-LLU Initiative for Maximizing Student DiversityR25GM060507 · NIGMS · LOMA LINDA UNIVERSITY · PI DE LEON, MARINO · 2001 to 2022
$11.3M
Research Training/Education CoreP20MD006988 · NIMHD · LOMA LINDA UNIVERSITY · PI CASIANO, CARLOS A. · 2012 to 2016
$6.2M
Targeted activation of autoimmune checkpoints in B cell malignanciesR01CA157644 · NCI · YALE UNIVERSITY · PI Markus Müschen · 2011 to 2026
$5.7M
PENN STATE CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR033184 · NCRR · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2011 to 2011
$4.5M
Statistical methods for improving reproducibility and utility of sequencing dataR01GM109453 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI LI, QUNHUA · 2013 to 2022
$2.3M
The Role of Zinc Finger Genes in LeukemogenesisR01HL095120 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI DOVAT, SINISA · 2009 to 2013
$1.8M
Xenograft Model to Study Impact of CRLF2-Ligand in Hispanic Childhood B-ALLR21CA162259 · NCI · LOMA LINDA UNIVERSITY · PI PAYNE, KIMBERLY J · 2012 to 2013
$346k
Cancer Research UK 18131NCATS NIH HHS UL1 TR000127NCATS NIH HHS UL1 TR002014NCI NIH HHS R01 CA157644NCI NIH HHS R21 CA162259NCI NIH HHS R35 CA197628NCRR NIH HHS UL1 RR033184NHLBI NIH HHS R01 HL095120NIGMS NIH HHS R01 GM109453NIGMS NIH HHS R25 GM060507NIMHD NIH HHS P20 MD006988
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epigenesis, GeneticCasein Kinase IIGene Expression Regulation, NeoplasticHistone Deacetylase 1HumansIkaros Transcription FactorPrecursor B-Cell Lymphoblastic Leukemia-LymphomaCasein Kinase IIHDAC1 protein, humanHistone Deacetylase 1Ikaros Transcription FactorIKZF1 protein, human

Identifiers

PMID26639180
PMCPMC4889471
OpenAlexW2194616187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.